^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    MHB088C

    i
    Other names: MHB088C
    Associations

    News

    Trials
    Company:
    Minghui Pharma
    Drug class:
    Topoisomerase I inhibitor, B7-H3-targeted antibody-drug conjugate
    Related drugs:
    Associations

    News

    Trials
    over1year
    Study of MHB088C in Participants With Advanced or Metastatic Solid Tumors (clinicaltrials.gov)
    P1/2, N=48, Not yet recruiting, Minghui Pharmaceutical Pty Ltd
    New P1/2 trial • Metastases
    |
    MSI (Microsatellite instability)
    |
    MSI-H/dMMR
    |
    MHB088C